Robert Bermel, MD

Staff Neurologist, Neurological Institute's Mellen Center for Multiple Sclerosis, Cleveland Clinic

Articles by Robert Bermel, MD

ENSEMBLE Study Results, Ocrelizumab as Promising Early Treatment for MS: Robert A. Bermel, MD

May 8th 2023

The director of the Mellen Center for MS at Cleveland Clinic talked about the ENSEMBLE study results that were presented at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]

Linking the Latest Research to Clinical Care in MS: Robert Bermel, MD

ByRobert Bermel, MD

December 19th 2022

The director of the Mellen Center for MS at Cleveland Clinic offered an overview of the State of the Science Summit that was held on November 10, 2022, featuring a panel of expert clinicians. [WATCH TIME: 4 minutes]

The Current State and Future Promise of Neurology

ByImad Michel Najm, MD,Robert Bermel, MD

May 17th 2022

The importance of addressing disorders of the brain cannot be overstated, and doing so will be essential to our generation and generations to come.

Robert Bermel, MD

Articles by Robert Bermel, MD

ENSEMBLE Study Results, Ocrelizumab as Promising Early Treatment for MS: Robert A. Bermel, MD

Linking the Latest Research to Clinical Care in MS: Robert Bermel, MD

The Current State and Future Promise of Neurology

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Issues Complete Response Letter for Spinocerebellar Ataxia Agent Troriluzole

Dental Caries and Periodontal Disease Increase Ischemic Stroke Risk, Study Shows

FDA Feedback Provides Clarity for Phase 3 Trial of Neflamapimod in Dementia With Lewy Bodies

New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment

Understanding the Global Impact of the Honolulu Asian Aging Study: George W. Ross, MD